US 10745405
Glucuronide prodrugs of Janus kinase inhibitors
granted A61PA61P29/00
Quick answer
US patent 10745405 (Glucuronide prodrugs of Janus kinase inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P29/00